ZURICH/BERLIN, April 12 (Reuters) - The Swiss blue-chip SMI was seen opening 0.1 percent lower at 9,543 points on Friday, according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss stocks:
Stadler Rail’s initial public offering (IPO) issue price has been set at 38 Swiss francs per share, valuing the Swiss group at 3.8 billion francs ($3.79 billion), the company said on Friday ahead of its debut on the SIX Swiss Exchange. The issue price, which Reuters had reported on Thursday, was in the upper half of the original price range of 33 to 41 Swiss francs per share.
* Luzerner Kantonalbank AG: Q1 consolidated profit of CHF 50.7 million, up 0.6%; outlook 2019: consolidated net income in the range of between CHF 195 and 203 million
* Polyphor AG: antibiotic murepavadin receives U.S. FDA qualified infectious disease product designation in four new indications
* SGS SA: acquires PT WLN Indonesia, provider of water, soil and air testing services
* Airesis SA: total group revenues amount to CHF 152.9 million, up more than 9% yoy
* Banque Profile De Gestion expects a lower result in the first quarter than in the same period of the previous year. The bank aims to announce the result in early May.
* Tecan named Wael Yared as CTO and head of R&D, as well as a member of the management board, while Ulrich Kanter will continue to lead the operations division
* BB Biotech closed its current share buyback program
* Nestle said Dick Boer and Dinesh Paliwal were elected as new members of the board.
ALCON AG: SOCGEN CUTS TO SELL FROM BUY; CUTS TARGET PRICE TO SFR 44 FROM SFR 67
SONOVA HOLDING AG: DEUTSCHE BANK RAISES TARGET PRICE TO SFR 260 FROM SFR 240
No major economic data scheduled. (Reporting by Zurich newsroom and Berlin Speed Desk)